Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia; Department of Medical Biology, University of Melbourne, Parkville, Victoria 3052, Australia.
Biochemistry Department, School of Biomedical Sciences, University of Otago, PO Box 56, Dunedin 9054, New Zealand.
Curr Opin Struct Biol. 2017 Dec;47:95-104. doi: 10.1016/j.sbi.2017.07.004. Epub 2017 Aug 5.
Pseudoenzymes were first described more than 50 years ago, when it was recognised that a subset of proteins that are structurally homologous to active enzymes lack amino acids necessary for catalytic activity. Recently, interest in pseudoenzymes has surged as it has become apparent that they constitute ∼10% of proteomes and perform essential metabolic and signalling functions that can be experimentally distinguished from catalytic outputs of enzymes. Here, we highlight recent structural studies of pseudoenzymes, which have revealed the molecular basis for roles as allosteric regulators of conventional enzymes, as molecular switches and integrators, as hubs for assembling protein complexes, and as competitors of substrate availability and holoenzyme assembly. As structural studies continue to illuminate pseudoenzyme molecular mechanisms, we anticipate that our knowledge of the breadth of their biological functions will expand in parallel.
伪酶最早是在 50 多年前被描述的,当时人们认识到,结构上与活性酶同源的一组蛋白质缺乏催化活性所必需的氨基酸。最近,由于人们意识到伪酶约占蛋白质组的 10%,并且具有可以从酶的催化产物中实验区分出来的重要代谢和信号转导功能,因此对伪酶的兴趣大增。在这里,我们重点介绍伪酶的最新结构研究,这些研究揭示了作为传统酶的变构调节剂、分子开关和整合器、组装蛋白质复合物的枢纽以及作为底物可用性和全酶组装的竞争者的作用的分子基础。随着结构研究继续阐明伪酶的分子机制,我们预计它们的生物学功能的广泛知识将与之平行扩展。